science
plus
.abes.fr
|
explorer
À propos de :
Supplement Articles
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
skos:Concept
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Concept
New Facet based on Instances of this Class
Attributs
Valeurs
type
Concept
rdfs:label
Supplement Articles
skos:inScheme
http://hub.abes.fr/referentiel/ouparticlecategories
is
Subject
of
Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999
Prevention of Fungal and Hepatitis Virus Infections in Liver Transplantation
Role of Pharmacokinetics and Pharmacodynamics: Does the Dose Matter?
Evaluating the Safety of Combination Vaccine
Review of Assessments of the Human Health Risk Associated with the Use of Antimicrobial Agents in Agriculture
Challenges and Opportunities for Humanitarian Relief in Afghanistan
Scabies and Pediculosis Pubis: An Update of Treatment Regimens and General Review
Food and Water Safety for Persons Infected with Human Immunodeficiency Virus
Studies of Adipose Tissue Metabolism in Human Immunodeficiency Virus—Associated Lipodystrophy
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
Harm Reduction Actions as a Health Care Construction Process at a Public Health Center in Rosario, Argentina
Persistent Diarrhea, Arthritis, and Other Complications of Enteric Infections: A Pilot Survey Based on California FoodNet Surveillance, 1998-1999
Changes in the Etiology of Bacteremia in Febrile Neutropenic Patients and the Susceptibilities of the Currently Isolated Pathogens
Mechanical Loading and Off-Loading of the Plantar Surface of the Diabetic Foot
Clinical Trials of Antifungal Prophylaxis among Patients in Surgical Intensive Care Units: Concepts and Considerations
Stable Antimicrobial Susceptibility Rates for Clinical Isolates of Pseudomonas aeruginosa from the 2001-2003 Tracking Resistance in the United States Today Surveillance Studies
Medical Examinations at Entry to Treatment for Drug Abuse as an Opportunity to Initiate Care for Hepatitis C Virus Infection
Knowledge and Attitudes about Treatment for Hepatitis C Virus Infection and Barriers to Treatment among Current Injection Drug Users in Australia
Successful Use of Amphotericin B Lipid Complex in the Treatment of Cryptococcosis
Integrating Care for Hepatitis C Virus (HCV) and Primary Care for HIV for Injection Drug Users Coinfected with HIV and HCV
New Drug Targets for HIV and Hepatitis C Virus Coinfection
Tumor Necrosis Factor and Chemokine Interactions in the Formation and Maintenance of Granulomas in Tuberculosis
The Global Status of Resistance to Antiretroviral Drugs
Emerging Metallo-β-Lactamase-Mediated Resistances: A Summary Report from the Worldwide SENTRY Antimicrobial Surveillance Program
Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosa
Microbiology of Antibiotic Resistance in Staphylococcus aureus
State of the Art for Diagnosis of HIV Infection
Strategies for Primary HIV Prevention That Target Behavioral Change
Broad-Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up Front
Scenario 1: A Patient with Mild Community-Acquired Pneumonia—Introduction to Clinical Trial Design Issues
The Pneumonia Severity Index: A Decade after the Initial Derivation and Validation
Invasive Pneumococcal Disease among Children in Rural Bangladesh: Results from a Population-Based Surveillance
The Clinical Importance of Microbiological Findings in the Diagnosis and Management of Bloodstream Infections
Clinical and Economic Consequences of Ventilator-Associated Pneumonia
HIV Infection—Related Tuberculosis: Clinical Manifestations and Treatment
Scenario 1: A Patient with Hospital-Acquired Bacterial Pneumonia—Introduction to Clinical Trial Design Issues
Review of Recent Clinical Trials of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Perspective from Academia
Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital-Acquired and Ventilator-Associated Pneumonia
Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Surrogate Markers and Microbiologic End Points
Posttransplant Microbiological Surveillance
Perspective on Animal Models: Chronic Intracellular Infections
Combination Vaccines: Postlicensure Safety Evaluation
Endemic Infectious Diseases of Afghanistan
Emerging Bone Problems in Patients Infected with Human Immunodeficiency Virus
Introduction the Forum Report on Advances in the Design of Antifungal Clinical Trials
Opiate Drug Use: A Potential Contributor to the Endocrine and Metabolic Complications in Human Immunodeficiency Virus Disease
Dietary Habits and Their Association with Metabolic Abnormalities in Human Immunodeficiency Virus—Related Lipodystrophy
Case Management of Human Immunodeficiency Virus—Infected Injection Drug Users: A Case Study in Rio de Janeiro, Brazil
HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms
Dramatic Decrease in the Incidence of Salmonella Serotype Enteritidis Infections in 5 FoodNet Sites: 1996-1999
Hospitalizations and Deaths Due to Salmonella Infections, FoodNet, 1996-1999
The Continuing Challenge of Lower Respiratory Tract Infections
Increased Antibiotic Resistance in Respiratory Tract Pathogens: PROTEKT US—An Update
Epidemiology and Natural History of Hepatitis C Virus Infection in Injection Drug Users: Implications for Treatment
Integrating Services for Injection Drug Users Infected with Hepatitis C Virus with Methadone Maintenance Treatment: Challenges and Opportunities
Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment
Medical Management of HIV—Hepatitis C Virus Coinfection in Injection Drug Users
Delivering Therapy for Hepatitis C Virus Infection to Incarcerated HIV-Seropositive Patients
Therapeutic Interventions for HIV Infection and Chronic Viral Hepatitis
Clinical Implications of Pharmacokinetics and Pharmacodynamics of Fluoroquinolones
Cytokine Promoter Polymorphisms in Severe Sepsis
Predicting and Defining Vancomycin Efficacy: Program Overview
Predicting and Defining Vancomycin Efficacy: Posttest and Program Evaluation
Rubella Immunity Levels in the United States Population: Has the Threshold of Viral Elimination Been Reached?
Micronutrients and Diarrheal Disease
Therapy for and Prevention of Traveler's Diarrhea
The Far-Reaching Impact of Antimicrobial Resistance
Principles of Antibiotic Therapy in Severe Infections: Optimizing the Therapeutic Approach by Use of Laboratory and Clinical Data
Impact of Counseling in Voluntary Counseling and Testing Programs for Persons at Risk for or Living with HIV Infection
Preclinical Testing in the Development of Probiotics: A Regulatory Perspective with Bacillus Strains as an Example
Performance of an Algorithm for Assessing Smallpox Risk among Patients with Rashes That May Be Confused with Smallpox
Methicillin-Resistant Staphylococcus aureus: An Evolving Clinical Challenge
Skin and Soft-Tissue Infections Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus
Historical and Regulatory Perspectives on the Treatment Effect of Antibacterial Drugs for Community-Acquired Pneumonia
Use of Pharmacokinetics and Pharmacodynamics in a Failure Analysis of Community-Acquired Pneumonia: Implications for Future Clinical Trial Study Design
Behind the Data: Establishing the Network for Surveillance of Pneumococcal Disease in the East African Region
Incidence, Seasonality, Age Distribution, and Mortality of Pneumococcal Meningitis in Burkina Faso and Togo
Clinical Consensus Conference: Survey on Gram-Positive Bloodstream Infections with a Focus on Staphylococcus aureus
Staphylococcus aureus Bloodstream Infections: Definitions and Treatment
Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005-2007)
Transmission of Drug-Susceptible and Drug-Resistant Tuberculosis and the Critical Importance of Airborne Infection Control in the Era of HIV Infection and Highly Active Antiretroviral Therapy Rollouts
Tuberculosis as Part of the Natural History of HIV Infection in Developing Countries
The Argument against Using Quantitative Cultures in Clinical Trials and for the Management of Ventilator-Associated Pneumonia
Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Clinical vasculitis
Clinical Presentations of Soft-Tissue Infections and Surgical Site Infections
Association between Antibiotic Resistance and Community Prescribing: A Critical Review of Bias and Confounding in Published Studies
Perspectives on the Manufacture of Combination Vaccines
Clinical Relevance of Macrolide-Resistant Streptococcus pneumoniae for Community-Acquired Pneumonia
Select Findings and Conclusions
Evolution of Anaerobe Susceptibility Testing in the United States
Microbial Resistance: Bacteria and More
Alternative Treatment Modalities in Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
Invasive Aspergillosis in the Setting of Cardiac Transplantation
Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Levofloxacin versus Ceftriaxone Sodium and Erythromycin Followed by Clarithromycin and Amoxicillin- Clavulanate in the Treatment of Serious Community-Acquired Pneumonia in Adults
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 12
Go
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata